JP2022535102A5 - - Google Patents
Info
- Publication number
- JP2022535102A5 JP2022535102A5 JP2021571915A JP2021571915A JP2022535102A5 JP 2022535102 A5 JP2022535102 A5 JP 2022535102A5 JP 2021571915 A JP2021571915 A JP 2021571915A JP 2021571915 A JP2021571915 A JP 2021571915A JP 2022535102 A5 JP2022535102 A5 JP 2022535102A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cancer
- polynucleotide
- composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025170954A JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Tgf-ベータワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1908012.6A GB201908012D0 (en) | 2019-06-05 | 2019-06-05 | TGF-Beta vaccine |
| GB1908012.6 | 2019-06-05 | ||
| PCT/EP2020/065472 WO2020245264A1 (en) | 2019-06-05 | 2020-06-04 | Tgf-beta vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170954A Division JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Tgf-ベータワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535102A JP2022535102A (ja) | 2022-08-04 |
| JP2022535102A5 true JP2022535102A5 (cg-RX-API-DMAC7.html) | 2023-06-14 |
| JP7758573B2 JP7758573B2 (ja) | 2025-10-22 |
Family
ID=67385796
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571915A Active JP7758573B2 (ja) | 2019-06-05 | 2020-06-04 | Tgf-ベータワクチン |
| JP2025170954A Pending JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Tgf-ベータワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170954A Pending JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Tgf-ベータワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220315634A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3980449A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7758573B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220018566A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113966342B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020287902B9 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3141744A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201908012D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL288673A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021014856A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202112416XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020245264A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021409832A1 (en) * | 2020-12-23 | 2023-08-10 | Korea Institute Of Science And Technology | NOVEL PEPTIDE CAPABLE OF INHIBITING TGF-β SIGNALING AND USE THEREOF |
| US20250327041A1 (en) | 2022-02-24 | 2025-10-23 | Io Biotech Aps | Nucleotide delivery of cancer therapy |
| US20250339504A1 (en) * | 2022-05-18 | 2025-11-06 | National Cancer Center | Cancer vaccine with use of common cancer antigen cocktail, tcr/car-t cell therapeutic, companion diagnostic method, and method for diagnosing risk of cancer onset by detecting circulating tumor cells |
| GB202215997D0 (en) | 2022-10-28 | 2022-12-14 | Io Biotech Aps | Therapy |
| GB202216449D0 (en) | 2022-11-04 | 2022-12-21 | Io Biotech Aps | TGF-BETA1 vaccine |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US58767A (en) | 1866-10-16 | John brougjbton | ||
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| US5420243A (en) * | 1993-01-26 | 1995-05-30 | Celtrix Pharmaceuticals, Inc. | Biologically active TGF-β2 peptides |
| EP0877031A1 (en) * | 1997-05-06 | 1998-11-11 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | TGF-Beta1 derived peptides mimicking the activity of transforming growth factor-Beta1 |
| EP0922710A4 (en) * | 1997-05-12 | 2002-10-25 | Kyowa Hakko Kogyo Kk | PEPTIDES SUPPORTING THE ACTIVATION OF LATENT TGF-BETA AND A METHOD FOR IDENTIFYING REGULATORS OF TGF-BETA ACTIVITY. |
| US6500920B1 (en) * | 1997-06-19 | 2002-12-31 | St. Louis University | Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor |
| ES2146552B1 (es) * | 1998-11-24 | 2001-04-16 | Inst Cientifico Tecnol Navarra | Peptidos inhibidores de tgf/31 |
| AU2001246393A1 (en) * | 2000-03-31 | 2001-10-08 | Vaccine Chip Technology Aps | Immunostimulating properties of a fragment of tgf-beta |
| US8158589B2 (en) * | 2003-08-22 | 2012-04-17 | Proyecto Biomedicine Cima, S.L. | Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) |
| WO2005105144A1 (ja) * | 2004-04-30 | 2005-11-10 | Kyowa Hakko Kogyo Co., Ltd. | 潜在型TGF-βの活性化抑制剤 |
| AU2005337776B2 (en) * | 2005-10-24 | 2013-01-31 | Proyecto De Biomedicina Cima, S.L. | Use of TGF-Beta1 inhibitor peptides in the preparation of an immune response modulating agent |
| JP2011519266A (ja) * | 2008-03-21 | 2011-07-07 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | 免疫反応の調節 |
| RU2012107535A (ru) * | 2009-07-30 | 2013-09-10 | Антисенс Фарма Гмбх | КОМБИНАЦИЯ ХИМИОТЕРАПЕВТИЧЕСКОГО СРЕДСТВА И ИНГИБИТОРА СИСТЕМЫ TGF-β |
| CN103087173B (zh) * | 2013-01-16 | 2014-07-16 | 西安交通大学医学院第一附属医院 | 基于TGF-β1的B细胞抗原表位的合成肽疫苗及其应用 |
| HRP20201914T1 (hr) * | 2013-05-06 | 2021-01-22 | Scholar Rock, Inc. | Sastavi i postupci za modulaciju faktora rasta |
| EP4050020A1 (en) * | 2014-03-11 | 2022-08-31 | University of Florida Research Foundation, Inc. | Aav-expressed m013 protein as an anti-inflammatroy therapeutic for use in a method of treating inflammatory ocular disease |
| AU2017254477A1 (en) * | 2016-04-18 | 2018-11-01 | Jennifer G. ABELIN | Improved HLA epitope prediction |
-
2019
- 2019-06-05 GB GBGB1908012.6A patent/GB201908012D0/en not_active Ceased
-
2020
- 2020-06-04 CN CN202080040978.4A patent/CN113966342B/zh active Active
- 2020-06-04 AU AU2020287902A patent/AU2020287902B9/en active Active
- 2020-06-04 CA CA3141744A patent/CA3141744A1/en active Pending
- 2020-06-04 MX MX2021014856A patent/MX2021014856A/es unknown
- 2020-06-04 EP EP20731430.3A patent/EP3980449A1/en active Pending
- 2020-06-04 JP JP2021571915A patent/JP7758573B2/ja active Active
- 2020-06-04 US US17/616,382 patent/US20220315634A1/en active Pending
- 2020-06-04 SG SG11202112416XA patent/SG11202112416XA/en unknown
- 2020-06-04 WO PCT/EP2020/065472 patent/WO2020245264A1/en not_active Ceased
- 2020-06-04 KR KR1020227000403A patent/KR20220018566A/ko active Pending
-
2021
- 2021-12-05 IL IL288673A patent/IL288673A/en unknown
-
2025
- 2025-10-09 JP JP2025170954A patent/JP2026010046A/ja active Pending
-
2026
- 2026-01-16 AU AU2026200314A patent/AU2026200314A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7871816B2 (en) | Vector for anti-HPV vaccine and transformed microorganism by the vector | |
| JP2003518931A (ja) | Hivに対する免疫応答における改善、または免疫応答に関する改善 | |
| ES2373055T3 (es) | Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno. | |
| EP2391383B1 (en) | Codon-optimized hepatitis b virus core antigen (hbcag) | |
| RU2007119319A (ru) | Наборы антигенов полипептида, угнетающего секрецию желудка (gip), и их применение | |
| EA016818B1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| JP2022507373A5 (cg-RX-API-DMAC7.html) | ||
| JP2024513559A5 (cg-RX-API-DMAC7.html) | ||
| CN117987471A (zh) | 一种重组病毒载体、包含其的免疫组合物以及用途 | |
| CA2432971A1 (en) | Polypeptides | |
| CA2106093A1 (en) | Recombinant anticoccidial vaccine | |
| CN107510841B (zh) | 源头阻断包虫病病原细粒棘球绦虫传播的疫苗 | |
| CN105073989A (zh) | 免疫原性多肽表层表达双歧杆菌 | |
| US8207141B2 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
| JP2009520472A (ja) | 腫瘍抗原由来最適化潜在性ペプチドで構成される免疫原性ポリペプチド及びその使用 | |
| JP2003522195A (ja) | 肝細胞癌の治療のための方法及び組成物 | |
| CN114805607A (zh) | EGFRvIII-PDL1-GMCSF肿瘤疫苗及其制备方法和应用 | |
| JP4459060B2 (ja) | ポリヌクレオチドからなるワクチン | |
| CN104974247B (zh) | 人肺靶向性抗肺泡表面活性蛋白a的纳米抗体及其制备方法 | |
| CN101302524A (zh) | 弓形虫多表位基因与霍乱毒素ctxa2/b亚基的融合基因及应用 | |
| JP2002510496A (ja) | 細胞傷害性t細胞を誘導するための医薬 | |
| RU2005101744A (ru) | Последовательность днк и получение аллергена пыльцы трав ph1 p4 с помощью рекомбинантных способов | |
| JPWO2007018198A1 (ja) | Hla−a2陽性者用hsp105由来癌拒絶抗原ペプチド及びこれを含む医薬 | |
| CN102838679A (zh) | Her2-neu抗原阳性肿瘤治疗性疫苗的制备及应用 | |
| Milani et al. | HSP roles as biomarkers and antigens in bacterial and viral infections |